Connect with us

Press Releases

MYOS CORP Announces Positive Results from Mobility and Quality of Life Study

Dogs supplemented with fortetropin experienced statistically significant improvements in LOAD (Liverpool Osteoarthritis in Dogs) scores.

mm

Published

on

(PRESS RELEASE) CEDAR KNOLLS, NJ — MYOS Corp, a research-based advanced nutrition company with divisions that address both Human Nutrition and Animal Health announced its positive results from a randomized, double blind, placebo-controlled veterinary clinical study that it sponsored at Kansas State University to examine the impact of Fortetropin on the quality of life and mobility in geriatric dogs. 90% of dogs that are five years of age or older suffer from osteoarthritis, a painful condition that can severely impact their mobility and quality of gains in muscle tissue in multiple clinical studies involving humans. life. Fortetropin is an advanced nutrition product marketed by MYOS that has been shown to accelerate gains in muscle tissue in multiple clinical studies involving humans.

This most recent study completed at Kansas State University involved supplementing geriatric dogs with a nutrition product, with half of the dogs enrolled receiving Fortetropin and the other half of the dogs enrolled receiving a macronutrient-matched placebo. Dog owners were required to complete a standardized questionnaire called LOAD (Liverpool Osteoarthritis in Dogs). The LOAD questionnaire was developed and validated by veterinarians and veterinary researchers at the University of Liverpool, United Kingdom, and has been used extensively in clinical studies on canine osteoarthritis published in the peer-reviewed literature. The LOAD questionnaire is comprised of 13 questions that relate to general mobility in addition to the capability to perform exercise. Each question is assigned a score from 0 to 4 with higher scores corresponding to increased severity of osteoarthritis.

Advertisement

FEATURED VIDEO

Sponsored by Cogent Solutions Group

Reduce Your Pet’s Hip & Joint Discomfort with the Most Researched Hyaluronan on the Market

Nearly 60% of dogs and 90% of cats suffer from joint discomfort. Trixsyn joint supplement contains a patented and proven hyaluronic acid molecule for maximum efficacy to promote joint, bone, soft tissue, and cartilage health, keeping your pet feeling comfortable, for longer. Trixsyn is veterinarian recommended, safe and all-natural, and contains research-proven ingredients. Get your paws on the most-researched hyaluronic acid on the market. Learn more at Trixsyn.com.

Promoted Headlines

Most Popular